Erlotinib hydrochloride

CAS: 183319-69-9

Ref. TM-T0373L

Produktinformation

• Name: Erlotinib hydrochloride
• Synonyme: OSI-744, NSC 718781, Erlotinib HCl, CP-358774, 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1), 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride, 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride, Cp 358774, Erlotinib HCl, Erlotinib Hcl Salt, Erlotinib, Hydrochloride Salt, Erlotinib, OS-774, N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide, N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4- Hydrochloride, N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine Hydrochloride, N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride (1:1), N-(4-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride (1:1), Osi 774, Tarceva, [6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride, [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine, quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva
• CAS: 183319-69-9

Beschreibung

Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 429.9
• Formel: C₂₂H₂₃N₃O₄·HCl
• Reinheit: 99.79%
• Farbe/Form: White Or Off-White Powder